Drugs in MeSH Category Cardiovascular Agents
✉ Email this page to a colleague
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hetero Labs Ltd Iii | INDOMETHACIN | indomethacin | CAPSULE;ORAL | 091240-001 | Apr 12, 2011 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Cadila | INDOMETHACIN | indomethacin | CAPSULE;ORAL | 090403-002 | Nov 15, 2010 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Vkt Pharma | RANOLAZINE | ranolazine | TABLET, EXTENDED RELEASE;ORAL | 214035-002 | Jan 19, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Vkt Pharma | RANOLAZINE | ranolazine | TABLET, EXTENDED RELEASE;ORAL | 214035-001 | Jan 19, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |